Kaohsiung Journal of Medical Sciences
Volume 24, Issue 8 , Pages 392-397 , August 2008

Anti-metastatic Action of Non-steroidal Anti-inflammatory Drugs

  • Wen-Chun Hung

      Affiliations

    • Corresponding Author InformationAddress correspondence and reprint requests to: Dr Wen-Chun Hung, Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan

Received 20 August 2008 ,Accepted 30 August 2008.

References 

  1. Waddell WR , Loughry RW . Sulindac for polyposis of the colon . J Surg Oncol . 1983;24:83–87
  2. Thun MJ , Namboodiri MM , Heath CW . Aspirin use and reduced risk of fatal colon cancer . N Engl J Med . 1991;325:1593–1596
  3. Altorki NK , Keresztes RS , Port JL , et al.   Celecoxib, a selective cyclooxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer . J Clin Oncol . 2003;21:2645–2650
  4. Crane CH , Mason K , Janjan NA , et al.   Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer . Am J Clin Oncol . 2003;26:S81–S84
  5. Konturek PC , Konturek SJ , Bielanski W , et al.   Influence of COX-2 inhibition by rofecoxib on serum and tumor progastrin and gastrin levels and expression of PPARgamma and apoptosis-related proteins in gastric cancer patients . Dig Dis Sci . 2003;48:2005–2017
  6. Pruthi RS , Derksen JE , Moore D . A pilot study of use of the cyclooxygenase-2 inhibitor celecoxib in recurrent prostate cancer after definitive radiation therapy or radical prostatectomy . BJU Int . 2004;93:275–278
  7. Vane JR . Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs . Nat New Biol . 1971;231:232–235
  8. Griswold DE , Adams JL . Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date . Med Res Rev . 1996;16:181–206
  9. Wu KK . Biochemical pharmacology of nonsteroidal anti-inflammatory drugs . Biochem Pharmacol . 1998;55:543–547
  10. Dubois RN , Abramson SB , Crofford L , et al.   Cyclooxygenase in biology and disease . FASEB J . 1998;12:1063–1073
  11. Simmons DL , Botting RM , Hla T . Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition . Pharmacol Rev . 2004;56:387–437
  12. Eberhart CE , Coffey RJ , Radhika A , et al.   Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas . Gastroenterology . 1994;107:1183–1188
  13. Hwang D , Scollard D , Byrne J , et al.   Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer . J Natl Cancer Inst . 1998;90:455–460
  14. Okami J , Yamamoto H , Fujiwara Y , et al.   Overexpression of cyclooxygenase-2 in carcinoma of the pancreas . Clin Cancer Res . 1999;5:2018–2024
  15. Tucker ON , Dannenberg AJ , Yang EK , et al.   Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer . Cancer Res . 1999;59:987–990
  16. Hida T , Yatabe Y , Achiwa H , et al.   Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas . Cancer Res . 1998;58:3761–3764
  17. Cohen EG , Almahmeed T , Du B , et al.   Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma . Clin Cancer Res . 2003;9:3425–3430
  18. Pai R , Soreghan B , Szabo IL , et al.   Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy . Nat Med . 2002;8:289–293
  19. Mutoh M , Watanabe K , Kitamura T , et al.   Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis . Cancer Res . 2002;62:28–32
  20. Tsujii M , Kawano S , Tsuji S , et al.   Cyclooxygenase regulates angiogenesis induced by colon cancer cells . Cell . 1998;93:705–716
  21. Gately S . The contributions of cyclooxygenase-2 to tumor angiogenesis . Cancer Metastasis Rev . 2000;19:19–27
  22. Lin MT , Lee RC , Yang PC , et al.   Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway . J Biol Chem . 2001;276:48997–49002
  23. Sorokin A . Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype . Curr Pharm Des . 2004;10:647–657
  24. Huang M , Sharma S , Mao JT , et al.   Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production . J Immunol . 1996;157:5512–5520
  25. Dermond O , Ruegg C . Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives . Drug Resist Updat . 2001;4:314–321
  26. Costa C , Soares R , Reis-Filho JS , et al.   Cyclooxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer . J Clin Pathol . 2002;55:429–434
  27. Grosch S , Maier TJ , Schiffmann S , et al.   Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors . J Natl Cancer Inst . 2006;98:736–747
  28. Cha YI , DuBois RN . NSAIDs and cancer prevention: targets downstream of COX-2 . Annu Rev Med . 2007;58:239–252
  29. Leahy KM , Koki AT , Masferrer JL . Role of cyclooxygenases in angiogenesis . Curr Med Chem . 2000;7:1163–1170
  30. Rao CV , Reddy BS . NSAIDs and chemoprevention . Curr Cancer Drug Targets . 2004;4:29–42
  31. Kardosh A , Blumenthal M , Wang WJ , et al.   Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines . Cancer Biol Ther . 2004;3:55–62
  32. Narayanan BA , Condon MS , Bosland MC , et al.   Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s) . Clin Cancer Res . 2003;9:3503–3513
  33. Grosch S , Tegeder I , Niederberger E , et al.   COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib . FASEB J . 2001;15:2742–2744
  34. Maier TJ , Schilling K , Schmidt R , et al.   Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells . Biochem Pharmacol . 2004;67:1469–1478
  35. Hung WC , Chang HC , Pan MR , et al.   Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells . Mol Pharmacol . 2000;58:1398–1403
  36. Huang YC , Chuang LY , Hung WC . Mechanisms under-lying nonsteroidal anti-inflammatory drug-induced p27(Kip1) expression . Mol Pharmacol . 2002;62:1515–1521
  37. Waskewich C , Blumenthal RD , Li H , et al.   Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines . Cancer Res . 2002;62:2029–2033
  38. Nam DH , Park K , Park C , et al.   Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib . Oncol Rep . 2004;11:263–268
  39. Wun T , McKnight H , Tuscano JM . Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma . Leuk Res . 2004;28:179–190
  40. Dandekar DS , Lopez M , Carey RI , et al.   Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells . Int J Cancer . 2005;115:484–492
  41. Chang HC , Weng CF . Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells . Oncol Rep . 2001;8:1321–1325
  42. Jazirehi AR , Bonavida B . Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis . Mol Cancer Ther . 2004;3:71–84
  43. Kern MA , Schubert D , Sahi D , et al.   Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells . Hepatology . 2002;36:885–894
  44. Kundu N , Smyth MJ , Samsel L , et al.   Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle . Breast Cancer Res Treat . 2002;76:57–64
  45. Li G , Yang T , Yan J . Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells . Biochem Biophys Res Commun . 2002;299:886–890
  46. Liu XH , Kirschenbaum A , Yao S , et al.   Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line . Clin Exp Metastasis . 1999;17:687–694
  47. Gately S , Li WW . Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy . Semin Oncol . 2004;31:2–11
  48. Ostrowski J , Wocial T , Skurzak H , et al.   Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors? . Br J Cancer . 2003;88:1143–1151
  49. Thyss R , Virolle V , Imbert V , et al.   NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death . EMBO J . 2005;24:128–137
  50. Thiel G , Cibelli G . Regulation of life and death by the zinc finger transcription factor Egr-1 . J Cell Physiol . 2002;193:287–292
  51. Stetler-Stevenson WG , Hewitt R , Corcoran M . Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic . Semin Cancer Biol . 1996;7:147–154
  52. Pupa SM , Ménard S , Forti S , et al.   New insights into the role of extracellular matrix during tumor onset and progression . J Cell Physiol . 2002;192:259–267
  53. Giannelli G , Falk-Marzillier J , Schiraldi O , et al.   Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5 . Science . 1997;277:225–228
  54. Abiru S , Nakao K , Ichikawa T , et al.   Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells . Hepatology . 2002;35:1117–1124
  55. Pan MR , Hung WC . Nonsteroidal anti-inflammatory drugs inhibit matrix metalloproteinase-2 via suppression of the ERK/Sp1-mediated transcription . J Biol Chem . 2002;277:32775–32780
  56. Pan MR , Chang HC , Hung WC . Non-steroidal anti-inflammatory drugs suppress the ERK signaling pathway via block of Ras/c-Raf interaction and activation of MAP kinase phosphatases . Cell Signal . 2008;20:1134–1141
  57. Banyai L , Patthy L . The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases . Protein Sci . 1999;8:1636–1642
  58. Egeblad M , Werb Z . New functions for the matrix metalloproteinases in cancer progression . Nat Rev Cancer . 2002;2:161–174
  59. Stetler-Stevenson M , Mansoor A , Lim M , et al.   Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells . Blood . 1997;89:1708–1715
  60. Takahashi C , Sheng Z , Horan TP , et al.   Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK . Proc Natl Acad Sci USA . 1998;95:13221–13226
  61. Liu LT , Chang HC , Chiang LC , et al.   Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells . Oncogene . 2002;21:8347–8350
  62. Pan MR , Chang HC , Chuang LY , et al.   The nonsteroidal anti-inflammatory drug NS398 reactivates SPARC expression via promoter demethylation to attenuate invasiveness of lung cancer cells . Exp Biol Med . 2008;233:456–462
  63. Framson PE , Sage EH . SPARC and tumor growth: where the seed meets the soil? . J Cell Biochem . 2004;92:679–690
  64. Moon Y , Bottone FG , McEntee MF , et al.   Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1 . Mol Cancer Ther . 2005;4:1551–1558
  65. Esteller M . Epigenetic gene silencing in cancer: the DNA hypermethylome . Hum Mol Genet . 2007;16:R50–R59

PII: S1607-551X(08)70162-1

doi: 10.1016/S1607-551X(08)70162-1

Kaohsiung Journal of Medical Sciences
Volume 24, Issue 8 , Pages 392-397 , August 2008

Article Tools